When multiple plaintiffs (hundreds, sometimes thousands) in different districts share common issues and their civil actions involve one or more common questions of fact, these cases can be consolidated into what is called “multidistrict litigation” or “MDL.” Currently, more than 200 Zofran cases have been consolidated into an MDL in Boston.
MDLs help streamline the legal process. By consolidating multiple, complex cases, the courts can speed up the legal process. This MDL contains multiple plaintiffs who are all making similar allegations – that taking Zofran while pregnant caused their child to be born with birth defects, that GlaxoSmithKline (the maker of Zofran) knew about the potential risks, and that the drug manufacturer failed to warn doctors and consumers of that risk.
You can read more detailed information about Zofran here, but essentially, Zofran (ondansetron) is an anti-nausea drug originally approved by the U.S. Food and Drug Administration (FDA) to treat cancer patients suffering from nausea after treatments such as chemotherapy. The drug was then (many claim wrongfully) marketed to pregnant women to treat morning sickness.
Many women are claiming that taking Zofran during their pregnancy caused their child to be born with cleft palate and other serious birth defects. If this applies to you, we invite you to contact our lawyers today for a review of your case. Domina Law Group is here to inform you of your legal rights and options if you took Zofran during your pregnancy.
Related Stories: